CA-BELKIN
7.6.2022 18:02:05 CEST | Business Wire | Press release
Belkin , a global consumer electronics leader, today announces three new additions to its growing SOUNDFORM audio portfolio – the SOUNDFORM Immerse Noise Cancelling Earbuds, the SOUNDFORM Play True Wireless Earbuds, and SOUNDFORM Nano Wireless Earbuds for Kids. The new SOUNDFORM solutions fill out Belkin’s vast true wireless audio collection, offering wireless earbuds for wide age ranges and at various price points.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607005084/en/
“Since launching the Belkin SOUNDFORM™ audio line just a few years ago, we introduced a variety of innovative audio solutions ranging from award-winning premium smart speakers to popular kids' headphones,” says Melody Tecson, senior director of product management, Belkin. “Our audio team has deep expertise in the acoustic industry and delivers high quality true wireless earbud solutions that will complement day-to-day activities from working out, taking work calls, or studying at home.”
SOUNDFORM™ Immerse Noise Cancelling Earbuds
Announced earlier this year at CES 2022, the SOUNDFORM Immerse Noise Cancelling Earbuds are Belkin’s top-of-the-line audio solution designed for true audiophiles who value a feature-rich solution and premium listening experience.
Key features:
- Hybrid ANC (Active Noise Cancellation) and 3 microphones per earbud filter and eliminate unwanted noise for clearer call quality and an ideal listening experience
- Hear-Thru mode enables users to adjust ambient sound levels so they can stay alert of their surroundings
- Multipoint connection offers seamless switching between multiple devices
- 12mm dual-layer dynamic drivers with neodymium magnets and aptX audio technology offer intensely vivid sounds and truly immersive audio moments
- 31 hours of battery life – 7 hours of playtime per charge for the earbuds, plus another 24 hours of battery in the wireless charging case for uninterrupted talking, listening, and streaming
- Locating capabilities with Apple Find My network to locate charging case, and Belkin Ping My Earbuds feature to locate earbuds
- Google Fast Pair allows Android phones to instantly connect with a simple tap
- Accompanying SOUNDFORM app provides advanced customization features such as personalized EQ settings and adjustable Hear-Thru levels
- Qi wireless charging case for quick and easy recharging
- IPX5-rated sweat and water resistance
- Black and White color options
SOUNDFORM™ Play True Wireless Earbuds
The SOUNDFORM Play True Wireless Earbuds are the next generation of Belkin’s original SOUNDFORM True Wireless Earbuds offering more features such as EQ presets, improved battery life, and four different color options at an affordable price.
Key features:
- Dual Beamforming technology with 2 microphones in each earbud reduces environmental noise and provides audio clarity on calls
- 38 hours of battery life — up to 8 hours of playtime for the earbuds, plus 30 hours in the charging case
- 3 touch-controllable EQ presets for personalized sound
- 6mm dynamic drivers deliver clear, dependable sound quality
- Fast USB-C charging fully charges case and buds in just 1.5 hours
- IPX5-rated sweat and water resistance
- Intuitive touch controls in both earbuds allows users to tap to skip tracks, answer calls and more
- Midnight, Cloud, Petal and Ocean color options
SOUNDFORM™ Nano Wireless Earbuds for Kids
The SOUNDFORM Nano Wireless Earbuds for Kids deliver safe, high-quality sound up to 85dB volume limit, all-day comfort and extended battery life so children ages 7+ can safely listen to audio. The SOUNDFORM Nano Wireless Earbuds join the SOUNDFORM Mini Wireless Headphones in Belkin’s audio collection specifically designed for kids.
Key features:
- Safe Sound for Kids 85dB volume limit protects young, sensitive hearing from loud sounds
- 5 different ear tip size options, including extra-extra small, assure a comfortable fit and premium listening experience for smaller ears
- 24 hours of battery life – up to 5 hours of non-stop playtime, with an additional 19 hours of battery life in the charging case
- 6mm dynamic driver in each earbud makes favorite songs come alive
- IPX5 water resistance keeps earbuds safe as kids splash through puddles, dash through light rain, and play carefree
- Case and earbuds are fully charged in just 2 hours with the included micro-USB cable
- Blue, Pink and White color options
Pricing and Availability
- The SOUNDFORM Immerse are now available to order for $179.99 USD on Belkin.com.
- The SOUNDFORM Play are now available to order for $59.99 USD on Belkin.com
- The SOUNDFORM Nano are now available to order for $49.99 USD on Belkin.com.
Imagery can be found HERE .
About Belkin
Belkin is an accessories market leader delivering power, protection, productivity, connectivity and audio solutions for a broad range of consumer electronics and enterprise environments. Designed in Southern California and sold in more than 50 countries around the world, Belkin creates products that empower people through technology whether at home, at work or on a new adventure. In 2018, Belkin International merged with Foxconn Interconnect Technology to bolster its global influence and remains forever inspired by people and the planet we live on.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607005084/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom